AI entity
All 1 tracked stories fall under one category: funding. NRL Capital is most often covered alongside Aureka Biotechnologies, which appears in 1 of these 1 story. NRL Capital appears in 1 tracked AI story from August 11, 2026. The tracked stories average 2 original sources each.
Last mentioned: Aug 11, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: funding. NRL Capital is most often covered alongside Aureka Biotechnologies, which appears in 1 of these 1 story. NRL Capital appears in 1 tracked AI story from August 11, 2026. The tracked stories average 2 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 9 AI stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering NRL Capital. Shared-story counts are live from our verified record — not editorial picks.
AI-native biotech Aureka Biotechnologies raised $100M in Series B to scale its biological foundation models and closed-loop experimentation platform. The company aims to build a ‘biological world model’—a generalist AI that learns the rules of biology, moving beyond narrow task-specific applications.
Source: prnewswire.com · manilatimes.net
NRL Capital is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
